You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

EULEXIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Eulexin patents expire, and when can generic versions of Eulexin launch?

Eulexin is a drug marketed by Schering and is included in one NDA.

The generic ingredient in EULEXIN is flutamide. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flutamide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Eulexin

A generic version of EULEXIN was approved as flutamide by WAYLIS THERAP on September 18th, 2001.

  Try a Trial

Drug patent expirations by year for EULEXIN
Recent Clinical Trials for EULEXIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fudan UniversityPhase 2
University of VirginiaPhase 1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 1

See all EULEXIN clinical trials

US Patents and Regulatory Information for EULEXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EULEXIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 ⤷  Try a Trial ⤷  Try a Trial
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 ⤷  Try a Trial ⤷  Try a Trial
Schering EULEXIN flutamide CAPSULE;ORAL 018554-001 Jan 27, 1989 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for EULEXIN

See the table below for patents covering EULEXIN around the world.

Country Patent Number Title Estimated Expiration
Japan S61118324 NOVEL THERAPEUTICAL COMPOSITION USING LH_RH OR AGONIST ⤷  Try a Trial
South Africa 8005791 ⤷  Try a Trial
Japan H059129 NEW THERAPEUTIC DRUG USING LH-RH OR AGONIST ⤷  Try a Trial
Japan H0479325 ⤷  Try a Trial
Australia 3726985 ⤷  Try a Trial
Japan S6237018 ⤷  Try a Trial
Japan 2761988 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.